In this advanced age, new things are being introduced through artificial intelligence. In this context, OpenAI has introduced GPT-Rosalind, a new model of Artificial Intelligence (AI) to promote biology-related knowledge and scientific research while expanding expertise in the field of life sciences.

According to the report, GPT-Rosaland, named after British scientist Rosalind Franklin, is designed to support research in the fields of biochemistry, drug discovery and disease diagnosis and treatment.

It was reported that the demand for AI-powered tools to accelerate the drug discovery and research process has increased among pharmaceutical companies, academic institutions and biotech firms. Researchers using this model will be able to retrieve information from databases, read the latest scientific papers, use other scientific tools, as well as make suggestions for new experiments, as the model is built on OpenAI’s latest internal models.

GPT is available to Rosalind in ChatGPT, Codex and API as a research preview to authorized users through OpenAI’s trusted access framework, while the company is also introducing a free Life Sciences Research Plugin for Codex that connects scientists to more than 50 scientific tools and data sources.

According to the company, this is a version of the latest flagship model, specially optimized for defensive cyber security. It should be noted that earlier OpenAI’s rival company Anthropic announced the new AI model Mythos, after which the new model of OpenAI has been brought forward.